Testosterone gel vs. injection: what TRT comparisons get wrong

What did @mytrt.health actually say?

Here is the uncomfortable truth about this video: the transcript contains no coherent medical claims whatsoever. The audio, as captured, is a stream of disconnected phrases about being surprised and having a training team. It does not match the caption's promise of a comparison between testosterone gels and injections. The caption, however, does make a real claim worth examining: that both delivery methods work, but there is "one decisive difference" patients should know. We will fact-check that claim, because it is the one this audience came to hear.

The caption also references application instructions for gel, including letting it dry and avoiding showering afterward. Those are accurate procedural points consistent with prescribing information for products like Testogel and AndroGel. Credit where it is due on that narrow detail.

Does the science back this up?

The claim that both gels and injections "work" for testosterone replacement therapy is accurate and well-supported. Where it gets more interesting is in what "work" actually means across delivery methods, because the pharmacokinetics are meaningfully different, and those differences have real clinical consequences.

Injections of testosterone cypionate or enanthate produce peaks and troughs. Levels spike in the days after injection, then fall, sometimes below normal range, before the next dose. This roller-coaster pattern is well-documented. Rastrelli et al. (2018, Sexual Medicine Reviews) noted that symptomatic fluctuations, including mood shifts and energy dips, are a common complaint with weekly or biweekly injection protocols. Shorter injection intervals, such as every three to five days, can smooth this curve considerably.

Transdermal gels, by contrast, deliver more stable daily levels when applied consistently. Swerdloff et al. (2000, Journal of Clinical Endocrinology and Metabolism) showed that AndroGel produced stable serum testosterone within 30 days of daily use, with less fluctuation than IM injections on standard schedules. The tradeoff is compliance burden and transfer risk.

What did they get wrong (or right)?

The caption gets the basics right. Both methods work. Daily application is genuinely required for gel. Waiting for it to dry and avoiding swimming or showering immediately after application are real instructions from product labeling, not invented warnings.

What the video does not address, and what any honest comparison should include, is transference risk. This is arguably the biggest practical difference between gels and injections. Skin-to-skin contact after gel application can transfer testosterone to partners and children. The FDA issued a black box warning about this specifically in 2009. Inadvertent exposure in children has been linked to premature puberty. That is not a minor footnote. Omitting it from a head-to-head comparison is a significant gap.

The video also skips over the fact that injectable testosterone is generally less expensive, requires less daily discipline, and may be preferable for patients who struggle with consistent daily routines. Neither method is universally superior. The right choice depends on lifestyle, lab monitoring, cost, and whether there are children or partners in the household who could be exposed to gel.

What should you actually know?

If you are considering TRT, the delivery method question is legitimate and worth discussing with a prescribing clinician, not resolving based on a social media caption. Here is what the evidence actually supports.

• Gels produce more stable daily testosterone levels than standard weekly injections, but require consistent daily use and carry a skin transfer risk that injections do not.
• Injections typically produce more pronounced peaks and troughs, which some men tolerate well and others find disruptive to mood and energy.
• More frequent injections, every three to five days, can reduce hormonal swings significantly.
• Subcutaneous injections are emerging as a lower-pain, easier self-administration option with comparable pharmacokinetics to IM, per Spratt et al. (2021, Journal of Endocrinological Investigation).
• No delivery method is automatically better. Patient preference, household composition, cost, and adherence capacity all matter.

Anyone prescribing or dispensing TRT should be monitoring hematocrit, PSA in appropriate populations, and lipid panels alongside testosterone levels. Delivery method affects monitoring schedules too, since gel users need labs drawn at consistent times post-application.

Bottom line on this video

The caption makes a defensible, if incomplete, comparison. The actual recorded content is unusable as health information. The format, a short social clip comparing two TRT delivery methods, is a legitimate public health service when done well. This one needed more depth on transference risk and a functioning audio track.